30

Byhealth Co LtdSHE 300146 Stock Report

Last reporting period 30 Jun, 2024

Updated 18 Sep, 2024

Last price

Market cap $B

2.57

Small

Exchange

XSHE - Shenzhen Stock Exchange

300146.SZ Stock Analysis

30

Uncovered

Byhealth Co Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

74/100

Moderate score

Market cap $B

2.57

Dividend yield

5.49 %

Shares outstanding

1 700.31 B

By-health Co., Ltd. engages in the research, development, production, and sales of vitamin and dietary supplements. The company is headquartered in Guangzhou, Guangdong and currently employs 3,888 full-time employees. The company went IPO on 2010-12-15. The firm's main products include protein powders, collagen protein, vitamin C tablets, vitamin B tablets, natural vitamin E capsules, vitamin A and D soft capsules, calcium and vitamin D soft capsules, bovine colostrum calcium tablets, bone collagen calcium tablets, spirulina tablets, grape seed tablets, wheat germ oil soft capsules, deep-sea fish oil soft capsules, tuna oil soft capsules, propolis soft capsules, soybean phospholipids soft capsules and squalene soft capsules, among others. The firm distributes products both in the domestic market and to overseas markets.

View Section: Eyestock Rating